CircRNAs and cancer: Biomarkers and master regulators

被引:312
|
作者
Arnaiz, Esther [1 ]
Sole, Carla [1 ]
Manterola, Lorea [1 ]
Iparraguirre, Leire [2 ]
Otaegui, David [2 ]
Lawrie, Charles H. [1 ,3 ,4 ]
机构
[1] Biodonostia Res Inst, Mol Oncol Grp, Paseo Doctor Begiristain S-N, San Sebastian 20014, Spain
[2] Biodonostia Res Inst, Multiple Sclerosis Grp, Paseo Doctor Begiristain S-N, San Sebastian 20014, Spain
[3] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England
[4] Ikerbasque, Basque Fdn Sci, Maria Diaz Haroko Kalea 3, Bilbao 48013, Spain
关键词
circRNA; Biomarkers; Liquid biopsies; Non-coding RNA; CIRCULAR RNA EXPRESSION; COLORECTAL-CANCER; GASTRIC-CANCER; CELL-PROLIFERATION; LUNG-CANCER; REVEALS; GENE; TRANSCRIPTS; BIOGENESIS; MIGRATION;
D O I
10.1016/j.semcancer.2018.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circular RNAs (circRNAs) are a novel class of regulatory RNAs that despite being relatively abundant have only recently begun to be explored. There are many thousands of genes that appear capable of producing circRNAs, however the function of all but a handful remain to be determined. What is emerging about these highly conserved molecules is that they play important roles in biology and cancer biology in particular. The most explored function of circRNAs is as master regulators of gene expression that act to sequester or 'sponge' other gene expression regulators, in particular miRNAs. They have also been demonstrated to function via direct modulation of transcription, and by interfering with splicing mechanisms. Although generally expressed in low abundance when compared to their linear counterparts, they are often expressed in a tissue- and developmental stage-specific manner. Coupled with their remarkable resistance to RNAse activity due to a covalent closed cyclic structure, circRNAs show great promise as novel biomarkers of cancer and other diseases. In this review we consider the current state of knowledge regarding these molecules, their synthesis, function, and association with cancer. We will also review some of the challenges that remain to be resolved if this emerging class of RNAs are really to become useful in the clinic.
引用
收藏
页码:90 / 99
页数:10
相关论文
共 50 条
  • [31] Profiling and integrated analysis of differentially expressed circRNAs as novel biomarkers for breast cancer
    Li, Zehuan
    Chen, Zhanghan
    Hu, Guohua
    Zhang, Yong
    Feng, Yanling
    Jiang, Ying
    Wang, Jin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (11) : 7945 - 7959
  • [32] circRNAs in Cancer
    Patop, Ines Lucia
    Kadener, Sebastian
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2018, 48 : 121 - 127
  • [33] Master Regulators of Apoptosis
    Iqbal, Muhammed Javed
    Rehman, Abdur
    Sadiq, Muhammad Adnan
    Farooqi, Ammad Ahmad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (03): : 849 - +
  • [34] MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?
    Voorhoeve, P. Mathijs
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1805 (01): : 72 - 86
  • [35] NOD-like receptors: master regulators of inflammation and cancer
    Saxena, Mansi
    Yeretssian, Garabet
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [36] MicroRNAs as master regulators of FOXO transcription factors in cancer management
    Rani, Madhu
    Kumari, Rashmi
    Singh, Shashi Prakash
    Devi, Annu
    Bansal, Preeti
    Siddiqi, Aisha
    Alsahli, Mohammed A.
    Almatroodi, Saleh A.
    Rahmani, Arshad Husain
    Rizvi, M. Moshahid Alam
    LIFE SCIENCES, 2023, 321
  • [37] Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
    Schito, Luana
    Semenza, Gregg L.
    TRENDS IN CANCER, 2016, 2 (12): : 758 - 770
  • [38] Peroxisomes and PPARs: Emerging role as master regulators of cancer metabolism
    Pratama, Anggi Muhtar
    Sharma, Mansi
    Naidu, Srivatsava
    Boemmel, Heike
    Prabhuswamimath, Samudyata C.
    Madhusudhan, Thati
    Wihadmadyatami, Hevi
    Bachhuka, Akash
    Karnati, Srikanth
    MOLECULAR METABOLISM, 2024, 90
  • [39] MR4Cancer: a web server prioritizing master regulators for cancer
    Ru, Beibei
    Tong, Yin
    Zhang, Jiangwen
    BIOINFORMATICS, 2019, 35 (04) : 636 - 642
  • [40] Cancer stem cells: master gatekeepers and regulators of cancer growth and metastasis Introduction
    Rich, Jeremy N.
    MEDICINE, 2016, 95